• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

IVD Trends and Market Update: November 2022

$5,000.00 – $10,000.00

Clear
SKU: 22-046 Categories: Diagnostics Market Research, in vitro diagnostic, IVD Tags: COVID-19, in vitro diagnostics, ivd Pages: 44
  • Description
  • Table of Contents
  • Latest reports

Description

What’s Driving Growth in the IVD Market in Q3 and the last half of 2022?

What Major Trends are Affecting the Market in Q3 and the last half of 2022?

How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2022?

What Product Trends and New Developments Will Shape the IVD Market in the last half of 2022?

Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from Kalorama’s analysts to reflect the latest information as of Q3 2022 with a publication date of November 2022.

The demand for testing and movement of current and new technologies has continued to demonstrate gains in most areas of the IVD market. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly evolving market picture. There are some growing segments in the market that have attracted industry attention. Among these are next-generation sequencing (NGS), personalized medicine and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular diagnostics are also segments of great market interest, anticipated to be a core part of the future of IVD. The IVD market remains dynamic, demonstrating constant innovations.

Kalorama Information continues to be diligent in outlining the IVD market and its rapidly changing landscape. Kalorama Information has been and continues to be superior in accessing the market due to the extensive experience of its authors and commitment by the company to present the most accurate data available.

Table of Contents

Chapter 1: Worldwide IVD Market – November 2022 Update

IVD Market Demand and Growth

  • Figure 1-1: Quarter-by-Quarter Segment Performance Commentary, 2022
  • Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2022 ($ million) (Clinical Chemistry; Immunoassays – non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c – lab; Hematology – Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology – Mass Spectrometry; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular – NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
  • Figure 1-2: IVD Segment Performance, Q1 2022 – Q4 2022e ($MN)
  • Figure 1-3: IVD Segment Performance, Total Market Value, 2022 ($MN)

COVID-19 Diagnostic Markets

  • Table 1-2: COVID-19 Product Sales — Immunoassay (Antigen, Serology), Molecular, Rapid — 2022  ($ millions)

Effect of COVID-19 on Market Segments

  • Table 1-3: IVD Market excluding and with COVID-19, 2022
  • Figure 1-4: IVD Market Distribution by Segment, 2022
  • Figure 1-5: IVD Market by COVID-19 and non-COVID markets, Quarterly Performance, 2022
  • Table 1-4: Global In Vitro Diagnostic Market – YoY Growth 2021-2022
  • Figure 1-6: Global In Vitro Diagnostic Market – YoY Growth 2021-2022

 

Chapter 2: Product Trends and New Developments

Selected New – Q3 2022 – Core IVD Product Launches, Developments and Trends

Clinical Chemistry

Flow Cytometry

Immunoassay

Mass Spectrometry

Molecular

Personalized Medicine

POC

Sequencing

Selected COVID-19 Developments – Q3 2022

  • Figure 2-1: COVID-19 Test Market by Type, Q1-Q3 2022 – COVID-19 Testing Wanes

Antigen/Antibody

Molecular

 

Chapter 3: Top IVD Market Participant Results

Selected Competitive Leader Updates

  • Figure 3-1: IVD Segment Growth by Leading Competitors, Change in Sales 2021-2022
  • Figure 3-2: Changes in Market Distribution for IVD Sales, 2019 – 2022 – Roche and Abbott Battle for #1 Spot
  • Figure 3-3: Comparison of Total Diagnostic Sales for Abbott vs Roche 2020-2022 (in millions $)

Q3 M&A Activity

  • Table 3-1: IVD-Relevant M&A Activity, 2022
  • Figure 3-4: Count of IVD Industry M&A Deals by Month, 2022

Abbott Laboratories

  • Table 3-2: Abbott Corporate Summary

Becton Dickinson and Co

  • Table 3-3: Becton Dickinson Corporate Summary

bioMérieux SA

  • Table 3-4: bioMérieux Corporate Summary

Danaher Corporation

  • Table 3-5: Danaher Corporation Summary

Hologic, Inc.

  • Table 3-6: Hologic Corporate Summary

QuidelOrtho Corporation

  • Table 3-7: QuidelOrtho Corporate Summary

Roche Diagnostic

  • Table 3-8: Roche Diagnostic Corporate Summary

Siemens Healthineers

  • Table 3-9: Siemens Healthineers Corporate Summary

Sysmex Corporation

  • Table 3-10:  Sysmex Corporate Summary

Thermo Fisher Scientific

  • Table 3-11: Thermo Fisher Scientific Corporate Summary

 

Chapter 4: New Opportunities

Artificial Intelligence Future Trends

At-Home Testing

Microfluidics in IVD

Telehealth

 

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00
  • Placeholder image

    Blood – The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

    $1,995.00 – $7,800.00
  • Placeholder image

    In Vitro Diagnostic Tests and Systems: The World Outside the United States

    $596.00 – $1,192.00
  • Placeholder image

    Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications

    $2,625.00 – $5,250.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Market for Medical Devices, 12th Edition The World Market for Liquid Biopsy, 2023
Scroll to top